Search
Search Constraints
You searched for: Author/Creator Martin-Mola, ELimit your search
- Martin-Mola, E [remove] 17
- 616.723005 17
- Rheumatism -- Periodicals 17
- AAG, Arthritis Action Group -- GI, gastrointestinal -- MP, musculoskeletal pain -- NSAIDs, non-steroidal anti-inflammatory drugs -- OA, osteoarthritis -- OTC, over the counter -- RA, rheumatoid arthritis 1
- ACR, American College of Rheumatology -- ASPIRE, Active Controlled Study of Patients Receiving Infliximab for Treatment of Rheumatoid Arthritis -- DAS, disease activity score -- DMARD, disease modifying antirheumatic drug -- ESCISIT, European Standing Committee for International Clinical Studies Including Therapeutics -- EULAR, European League Against Rheumatism -- RCT, randomised controlled trial -- TEMPO, Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes -- TICORA, Tight Control for Rheumatoid Arthritis study -- TNF, tumour necrosis factor 1
- ACR, American College of Rheumatology -- SCDAI, Simplified composite Disease Activity Index -- DAS28, 28-joint Disease Activity Score -- DMARD, disease-modifying antirheumatic drug -- HACA, human antichimeric antibody -- MTX, methotrexate -- SDAI, simplified Disease Activity Index -- TNF, tumour necrosis factor 1
- ASU, avocado soybean unsaponifiable -- CI, confidence interval -- COX-2, cyclo-oxygenase-2 -- CS, chondroitin sulphate -- CT, controlled trial -- CV, cardiovascular -- ES, effect size -- GI, gastrointestinal -- GS, glucosamine sulphate -- HA, hyaluronic acid -- ICER, incremental cost effectiveness ratio -- NNT, number needed to treat -- NSAIDs, non-steroidal anti-inflammatory drugs -- QALY, quality of life year -- OA, osteoarthritis -- OR, odds ratio -- PPI, proton pump inhibitor -- RCT, randomised controlled trial -- RR, relative risk -- SYSADOA, symptomatic slow acting drugs for OA -- THR, total hip replacement -- VAS, visual analogue scale 1
- CART, classification and regression tree -- K&L, Kellgren and Lawrence -- LR, likelihood ratio -- MRI, magnetic resonance imaging -- OA, osteoarthritis -- US, ultrasonography 1
- ES, effect size -- HA, hyaluronic acid -- NSAIDs, non-steroidal anti-inflammatory drugs -- OA, osteoarthritis -- QS, quality score -- RCT, randomised controlled trial -- TKR, total knee replacement 1
- ESCISIT -- EULAR -- hips -- osteoarthritis -- recommendation 1
- EULAR, European League Against Rheumatism -- KOA, knee osteoarthritis -- PCA, principal components analysis -- VAS, visual analogue scale 1